Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / SPA - Sparton Corporation Reports Fiscal 2018 Fourth Quarter Results


SPA - Sparton Corporation Reports Fiscal 2018 Fourth Quarter Results

Sparton Corporation (NYSE:SPA) today announced results for the fourth quarter of fiscal year 2018 ended July 1, 2018.

Fourth Quarter Financial Results and Highlights

Joseph J. Hartnett, Interim President & CEO, commented, "We are pleased to report that we closed the 2018 fiscal year with a total backlog of $320 million, made up of $148 million in our MDS segment and $172 million in our ECP segment. Gross margins also closed strong with consolidated gross margins reported at 21.9% for the quarter and 21.2% for the year. While this has been a year of significant challenges on a number of fronts, the management team remains committed to taking the steps necessary to improve our long-term operating performance."

Joseph G. McCormack, Senior Vice President & CFO, commented, “During the 2018 fiscal year, we reduced our total adjusted SG&A to $49.1 million from $50.9 million in the prior fiscal year. While we generated free cash flow of $13.8 million in the fourth quarter of fiscal 2018, we experienced a net outflow of cash for the year of $8.3 million as a result of working capital needs. Working capital was impacted in the current fiscal year by supply shortages in the marketplace of certain electronic components, resulting in higher prices and higher inventory levels caused by accelerated component purchases, and increased accounts receivables principally related to the timing of payments from the U.S. Navy for shipments near year-end.”

Consolidated:

  • Net sales of $100.5 million
  • Gross profit margin of 21.9%
  • SG&A expenses of $15.8 million or 15.7% of sales; adjusted SG&A of $12.4 million, 12.3% of sales
  • Earnings per share of $(0.03), adjusted earnings per share of $0.32
  • Adjusted EBITDA of $9.3 million, a 9.3% adjusted EBITDA margin

MDS Segment:

  • Gross sales of $62.5 million
  • Gross profit margin of 11.3%
  • Operating loss of $0.6 million
  • Adjusted EBITDA of $4.4 million, a 7.1% adjusted EBITDA margin
  • New program wins in Q4 have expected revenue of $12.5 million when fully ramped up into production
  • Trailing four quarter new program win revenue of $62.8 million, which continues to support our future organic growth
  • Backlog of $148 million

ECP Segment:

  • Gross sales of $41.1 million
  • Gross profit margin of 36.4%
  • Operating income of $8.0 million
  • Adjusted EBITDA of $9.8 million, a 23.9% adjusted EBITDA margin
  • Backlog of $172 million

SELECTED FINANCIAL DATA

 
 
For the Quarters Ended
 
For the Fiscal Years
Q4 FY18
 
Q4 FY17
2018
 
2017
(Dollars in thousands, except per share data)
Consolidated:
Net sales
$
100,470
$
104,386
$
374,990
$
397,562
Gross profit
21,998
21,801
79,398
71,899
Selling and administrative expenses
15,805
14,913
57,637
54,110
Operating income
1,829
4,538
9,531
7,621
Adjusted operating income (non-GAAP)
8,425
7,638
27,576
19,323
Earnings (loss) per share
(0.03
)
0.17
(0.84
)
0.13
Adjusted earnings per share (non-GAAP)
0.32
0.38
1.42
0.91
EBITDA (non-GAAP)
4,953
7,978
22,704
22,074
Adjusted EBITDA (non-GAAP)
9,316
9,727
33,127
26,741
Adjusted EBITDA margin (non-GAAP)
9.3
%
9.3
%
8.8
%
6.7
%
Free cash flow (non-GAAP)
$
13,784
$
13,895
$
(8,345
)
$
24,572
 
MDS Segment:
Gross sales
$
62,538
$
67,046
$
235,985
$
260,514
Intercompany sales
(3,139
)
(2,887
)
(12,085
)
(10,074
)
Net sales
59,399
64,159
223,900
250,440
Gross profit
7,061
9,100
27,178
31,441
Selling and administrative expenses
3,296
3,446
13,609
13,545
Allocation of corporate expenses
2,011
2,456
8,699
9,578
Operating income (loss)
(614
)
1,557
(2,103
)
1,307
Adjusted segment EBITDA (non-GAAP)
$
4,421
6,428
$
15,978
$
21,337
 
ECP Segment:
Gross sales
$
41,078
$
40,264
$
151,144
$
147,259
Intercompany sales
(7
)
(37
)
(54
)
(137
)
Net sales
41,071
40,227
151,090
147,122
Gross profit
14,937
12,701
52,220
40,458
Selling and administrative expenses
4,116
2,709
11,435
10,805
Allocation of corporate expenses
1,341
1,470
4,626
4,903
Operating income
7,984
7,813
32,102
21,593
Adjusted segment EBITDA (non-GAAP)
9,800
9,859
38,823
$
28,805
 

Liquidity and Capital Resources

As of July 1, 2018, Sparton Corporation ("the Company") had $32 million available under its $120 million credit facility that expires in September 2019. On May 3, 2018, the Company entered into Amendment No. 5 to its credit facility which provided for, among other things, increased permitted total funded debt to EBITDA ratio to 4.5x and reduced the facility from $125 million to $120 million. The Company was in compliance with its covenants as of July 1, 2018. Over the term of this agreement, the facility has been modified several times to allow for increases in this ratio, as well as other relief, to provide flexibility during the Company’s exploration of a sale transaction. The most recent amendment to the facility provides for an increase to the leverage ratio through September 30, 2018. We intend to restructure this facility upon its expiration in September 2019, or sooner as conditions dictate, to provide for appropriate ongoing liquidity. Renegotiating this facility will very likely require restructuring our long term debt and will increase the interest rates we pay on our long term debt. Additionally, we may require a further amendment or waiver to our facility after September 30, 2018 to provide for liquidity through the closing of a potential sale transaction or through our negotiation of a new debt structure if no sale transaction is consummated. We believe that we will be able to secure the appropriate debt structure for the Company if no sale transaction is consummated and that our bank group will provide for the necessary amendments or waivers while such a structure is negotiated.

Potential Sale Transaction

On March 5, 2018, the Company announced the termination by the Company and Ultra Electronics Holdings plc (“Ultra”) of their July 7, 2017 merger agreement as a result of the staff of the United States Department of Justice (the “DOJ”) informing the parties that it intended to recommend that the DOJ block the merger. At that time, the Company announced that it will seek to re-engage with parties that previously expressed an interest in acquiring all or a part of the Company and that are in a position to expeditiously proceed to effect such a transaction. There can be no assurance that any such process will result in the execution of a definitive agreement or the completion of a transaction.

Non-GAAP Financial Measures

In addition to reporting financial results in accordance with U.S. generally accepted accounting principles (“GAAP”), Sparton Corporation has provided certain non-GAAP financial measures as additional information for its operating results. These measures have not been prepared in accordance with GAAP and may be different from measures used by other companies. Whenever we use non-GAAP financial measures, we designate these measures, which exclude the effects of certain expenses and income, as “adjusted” and provide a reconciliation of non-GAAP financial measures to the most closely applicable GAAP financial measure. The non-GAAP financial measures eliminate or add certain items of expense and income from or to operating expense and income taxes. Management believes that this presentation is helpful to investors in evaluating the current operational and financial performance of our business and facilitates comparisons to historical results of operations. Management discloses this information along with a reconciliation of the comparable GAAP amounts to provide access to the detail and nature of adjustments made to GAAP financial results. While some of these excluded items have been periodically reported in our statements of operations, their occurrence in future periods depends on future business and economic factors, among other evaluation criteria, and the occurrence of such events and factors may frequently be beyond the control of management.

When we calculate adjusted earnings per share, adjusted EBITDA and other adjustments to the statements of income, we exclude certain expenses and income because we believe that they are not related directly to the underlying performance of our fundamental business operations. We exclude these measures when reviewing financial results and for business planning. Although these events are reflected in our GAAP financial statements, these transactions may limit the comparability of our fundamental operations with prior and future periods. We believe EBITDA and adjusted EBITDA are commonly used by financial analysts and others in the industries in which the Company operates and, thus, provides useful information to investors. The Company does not intend, nor should the reader consider, EBITDA or adjusted EBITDA to be an alternative to operating income, net income, net cash provided by operating activities or any other items calculated in accordance with GAAP. The Company's definition of adjusted EBITDA may not be comparable with other companies. Accordingly, the measurement has limitations depending on its use.

About Sparton Corporation

Sparton Corporation (NYSE:SPA), now in its 119th year, is a provider of complex and sophisticated electromechanical devices with capabilities that include concept development, industrial design, design and manufacturing engineering, production, distribution, field service and refurbishment. The primary markets served are Medical & Biotechnology, Military & Aerospace and Industrial & Commercial. Headquartered in Schaumburg, IL, Sparton currently has thirteen manufacturing locations and engineering design centers worldwide. Sparton's Web site may be accessed at www.sparton.com.

Safe Harbor and Fair Disclosure Statement

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting future results, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in Sparton’s filings with the Securities and Exchange Commission (SEC). The matters discussed in this press release may also involve risks and uncertainties concerning Sparton’s services described in Sparton’s filings with the SEC. In particular, see the risk factors described in Sparton’s most recent Form 10-K and Form 10-Q. Sparton assumes no obligation to update the forward-looking information contained in this press release.

Filing of Sparton Fiscal 2018 Form 10-K

The Company intends to file its Form 10-K with the Securities Exchange Commission by September 14, 2018.

CONSOLIDATING FINANCIAL INFORMATION - Q4 FISCAL YEAR 2018

(Dollars in thousands, except per share data)

 
 
Corporate
 
MDS
 
ECP
 
Total
Net sales
$
 

$

 

59,399
$
 
41,071
$
 
100,470
Cost of goods sold
 
52,338
 
26,134
 
78,472
 
Gross profit
7,061
14,937
$
21,998
Operating expenses:
Selling and administrative
8,393
3,296
4,116
15,805
Selling and administrative - Corp allocations
(3,352
)
2,011
1,341
Internal research and development
1,197
1,197
Amortization of intangible assets
1,420
299
1,719
Legal settlements
500
 
948
 
 
1,448
 
Total operating expenses
5,541
 
7,675
 
6,953
 
20,169
 
Income (loss) from operations
(5,541
)
(614
)
7,984
1,829
Interest expense, net
(2,121
)
(2,121
)
Other income (expense)
(4
)
(3
)
(15
)
(22
)
Income tax (expense) benefit
122
 
(86
)
 
36
 
Net income (loss)
$
 
(7,544
)
$
 
(703
)
$
 
7,969
 
$
 
(278
)
Income per share of common stock:
Basic
$
(0.03
)
Diluted
(0.03
)
Weighted average shares of common stock outstanding:
Basic
9,834,723
Diluted
9,834,723
 

CONSOLIDATING FINANCIAL INFORMATION - Q4 FISCAL YEAR 2017

(Dollars in thousands, except per share data)

 
 
Corporate
 
MDS
 
ECP
 
Total
Net sales
$
 
$
 
64,159
$
 
40,227
$
 
104,386
Cost of goods sold
 
55,059
 
27,526
 
82,585
 
Gross profit
9,100
12,701
21,801
Operating expenses:
Selling and administrative
8,758
3,446
2,709
14,913
Selling and administrative - Corp allocations
(3,926
)
2,456
1,470
Internal research and development
361
361
Amortization of intangible assets
 
1,641
 
348
 
1,989
 
Total operating expenses
4,832
 
7,543
 
4,888
 
17,263
 
Income (loss) from operations
(4,832
)
1,557
7,813
4,538
Interest expense, net
(1,113
)
3
(1,110
)
Other income (expense)
(3
)
16
18
31
Income tax (expense) benefit
(1,692
)
(80
)
 
(1,772
)
Net income (loss)
$
 
(7,640
)
$
 
1,496
 
$
 
7,831
 
$
 
1,687
 
Income per share of common stock:
Basic
$
0.17
Diluted
0.17
Weighted average shares of common stock outstanding:
Basic
9,834,723
Diluted
9,834,723
 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

 
 
For the Fiscal Years
2018
 
2017
($ in thousands)
Cash Flows from Operating Activities:
Operating activities, net of working capital changes
$
 
14,246
$
 
18,293
Net changes in working capital
(18,355
)
13,175
 
Cash Flows from Operating Activities
(4,109
)
31,468
Cash Flows from Investing Activities:
Capital expenditures
(4,236
)
(6,896
)
Other investing activities
23
 
22
 
Cash Flows from Investing Activities
(4,213
)
(6,874
)
Cash Flows from Financing Activities:
Net change in credit facility
10,000
(22,706
)
Other financing activities
(1,506
)
(1,032
)
Cash Flows from Financing Activities
8,494
 
(23,738
)
Change in Cash and Cash Equivalents
172
856
 
Cash and Cash Equivalents - Beginning
988
 
132
 
Cash and Cash Equivalents - Ending
$
 
1,160
 
$
 
988
 
 

CONDENSED CONSOLIDATED BALANCE SHEETS

 
 

July 1,

 

July 2,

2018

2017

($ in thousands)
Assets
Cash and cash equivalents
$
 
1,160
$
 
988
Accounts receivable, net
60,454
45,347
Inventories
72,406
60,248
Prepaid and other current assets
8,444
3,851
Property, plant and equipment, net
32,790
34,455
Goodwill
12,663
12,663
Other intangible assets, net
21,108
28,445
Other assets
22,977
 
31,146
 
Total assets
$
 
232,002
 
$
 
217,143
 
Liabilities and Shareholders’ Equity
Accounts payable
$
28,636
$
27,672
Accrued expenses and other current liabilities
38,486
26,580
Credit facility
84,500
74,500
Environmental
4,866
5,468
Pension
690
888
Other non-current liabilities
1,220
167
Shareholders’ Equity
73,604
 
81,868
 
Total Liabilities and Shareholders’ Equity
$
 
232,002
 
$
 
217,143
 
 

RECONCILIATION OF NON-GAAP MEASURES

 

EBITDA Reconciliation (Non-GAAP) - Q4 Fiscal Year 2018

(Dollars in thousands)

 
 
Corporate
 
MDS
 
ECP
 
Total
Net income (loss)
$
 
(7,544
)
$
 
(703
)
$
 
7,969
$
 
(278
)
Interest expense, net
2,121
2,121
Income tax expense (benefit)
(122
)
86
(36
)
Amortization of intangible assets
1,420
299
1,719
Depreciation
587
649
191
1,427
Selling and administrative - Corp allocations
(3,352
)
2,011
 
1,341
 
 
EBITDA, excluding corporate allocation
(8,310
)
3,463
9,800
4,953
Adjustments for nonrecurring operating expenses:
Stock-based compensation
(514
)
(514
)
Costs related to potential sale of Company
2,960
2,960
Legal and other settlements and related legal fees
959
 
958
 
 
1,917
 
Adjusted EBITDA, before corporate allocation
$
 
(4,905
)
$
 
4,421
 
$
 
9,800
 
$
 
9,316
 
 
Adjusted EBITDA, after corporate allocation
$
(1,553
)
$
2,410
$
8,459
$
9,316
 
Adjusted EBITDA margin
9.3
%
 

EBITDA Reconciliation (Non-GAAP) - Q4 Fiscal Year 2017

(Dollars in thousands)

 
 
Corporate
 
MDS
 
ECP
 
Total
Net income (loss)
$
 
(7,640
)
$
 
1,496
$
 
7,831
$
 
1,687
Interest expense, net
1,113
(3
)
1,110
Income tax expense (benefit)
1,692
80
1,772
Amortization of intangible assets
1,641
348
1,989
Depreciation
452
758
210
1,420
Selling and administrative - Corp allocations
(3,926
)
2,456
 
1,470
 
 
EBITDA, excluding corporate allocation
(8,309
)
6,428
9,859
7,978
Adjustments for nonrecurring operating expenses:
Stock-based compensation
638
638
Costs related to potential sale of company
1,111
 
 
 
1,111
 
Adjusted EBITDA, before corporate allocation
$
 
(6,560
)
$
 
6,428
 
$
 
9,859
 
$
 
9,727
 
 
Adjusted EBITDA, after corporate allocation
$
(2,634
)
$
3,972
$
8,389
$
9,727
 
Adjusted EBITDA margin
9.3
%
 

Adjusted EPS (Non-GAAP)

 
 
For the Quarters Ended
 
For the Fiscal Years
Q4 FY18
 
Q4 FY17
2018
 

2017

(Dollars in thousands, except per share data)
Earnings (loss) per share - diluted, as reported
$
 
(0.03
)
$
 
0.17
$
 
(0.84
)
$
 
0.13
Nonrecurring items
0.36
0.08
0.78
0.22
Amortization of intangible assets
0.12
0.13
0.54
0.56
Adjustments for Tax Act
(0.13
)
 
0.94
 
 
Adjusted earnings per share
$
 
0.32
 
$
 
0.38
 
$
 
1.42
 
$
 
0.91
 
 
Adjustments, net of tax:
Costs related to potential sale of Company
2,131
$
722
$
5,652
$
2,017
Legal and other settlements and related legal fees
1,380
2,058
Other nonrecurring adjustments
 
 
 
65
 
Total nonrecurring, net of tax
3,511
722
7,710
2,082
Amortization of intangible assets, net of tax
1,238
 
1,293
 
5,283
 
5,524
 
Total adjustments, net of tax
4,749
2,015
12,993
7,606
Adjustments for Tax Act
(1,303
)
 
9,197
 
 
Total adjustments
$
 
3,446
 
$
 
2,015
 
$
 
22,190
 
$
 
7,606
 
 

Adjusted SG&A and Operating Income (Non-GAAP)

 
 
For the Quarters Ended
Q4 FY18
 
Q4 FY17
 

Operating

 

Operating

SG&A

Income

SG&A

Income

(Dollars in thousands)
As reported
$
 
15,805
$
 
1,829
$
 
14,913
$
 
4,538
Percentage of sales
15.7
%
1.8
%
14.3
%
4.3
%
Adjustments:
Amortization of intangible assets
1,719
1,989
Costs related to potential sale of Company
2,960
2,960
1,111
1,111
Legal ad other settlements and related legal fees
469
 
1,917
 
 
 
Total adjustments
3,429
 
6,596
 
1,111
 
3,100
 
As adjusted
$
 
12,376
 
$
 
8,425
 
$
 
13,802
 
$
 
7,638
 
 
Adjusted percentage of sales
12.3
%
8.4
%
13.2
%
7.3
%
 
 
2018
2017

Operating

Operating

SG&A

Income

SG&A

Income

(Dollars in thousands)
As reported
57,637
9,531
$
54,111
$
7,621
Percentage of sales
15.4
%
2.5
%
13.6
%
1.9
%
Adjustments:
Amortization of intangible assets
7,337
8,498
Costs related to potential sale of Company
7,850
7,850
3,104
3,104
Legal and other settlements and related legal fees
710
2,858
Other nonrecurring adjustments
 
 
100
 
100
 
Total adjustments
8,560
 
18,045
 
3,204
 
11,702
 
As adjusted
$
 
49,077
 
$
 
27,576
 
$
 
50,907
 
$
 
19,323
 
 
Adjusted percentage of sales
13.1
%
7.4
%
12.8
%
4.9
%

View source version on businesswire.com: https://www.businesswire.com/news/home/20180913005960/en/

Media:
Sparton Corporation
Joe McCormack, 847-762-5800
ir@sparton.com

Copyright Business Wire 2018
Stock Information

Company Name: Sparton Corporation
Stock Symbol: SPA
Market: NYSE

Menu

SPA SPA Quote SPA Short SPA News SPA Articles SPA Message Board
Get SPA Alerts

News, Short Squeeze, Breakout and More Instantly...